Literature DB >> 8251183

Maternal and fetal immune responses during pregnancy.

I L Sargent1.   

Abstract

Pregnancy in the human presents a paradox for the mother's immune system as the mechanisms which are essential to protect her from infection have the potential to destroy her antigenically foreign fetus. The maternal decidua is comprised principally of immune cells and it is into this tissue that the fetal trophoblast must invade to establish the placenta. The major factor which appears to prevent the rejection of the trophoblast is its expression of HLA-G, a nonpolymorphic transplantation antigen. Both local and systemic nonspecific suppressor mechanisms have been described which may down-regulate maternal immune responses without significantly impairing the ability to fight infections, but there is little evidence to suggest that specific blocking factors (antibodies and suppressor cells) play an essential role. The placental barrier restricts the traffic of cytotoxic cells to the fetus, and cytotoxic antibodies are removed by the placenta before they reach the fetal circulation. Thus a combination of immune adaptations ensures the success of the pregnancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251183

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  19 in total

1.  Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells.

Authors:  G P Sacks; C W G Redman; I L Sargent
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 2.  The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development.

Authors:  Regina Sullivan; Donald A Wilson; Joram Feldon; Benjamin K Yee; Urs Meyer; Gal Richter-Levin; Avital Avi; Tsoory Michael; Michael Gruss; Jörg Bock; Carina Helmeke; Katharina Braun
Journal:  Dev Psychobiol       Date:  2006-11       Impact factor: 3.038

Review 3.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

4.  Prenatal maternal immune disruption and sex-dependent risk for psychoses.

Authors:  J M Goldstein; S Cherkerzian; L J Seidman; J-A L Donatelli; A G Remington; M T Tsuang; M Hornig; S L Buka
Journal:  Psychol Med       Date:  2014-03-26       Impact factor: 7.723

5.  Proliferative responses to recall antigens are associated with pregnancy outcome in women with a history of recurrent spontaneous abortion.

Authors:  B L Bermas; J A Hill
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 6.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

Review 7.  A pregnant possibility: crossing fetal tolerance with hematopoiesis.

Authors:  P Furmanski
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

Review 8.  Autistic disorder and viral infections.

Authors:  Jane E Libbey; Thayne L Sweeten; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

9.  Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response.

Authors:  Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Noppadol Chaiyasit; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

10.  The role of CD4+CD25bright regulatory T cells in the maintenance of pregnancy, premature rupture of membranes, and labor.

Authors:  Hyun-Joo Seol; Min-Jeong Oh; Ji-Eun Lim; Nan-Hee Jung; Soo-Young Yoon; Hai-Joong Kim
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.